• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

AstraZeneca's experimental drug disappoints in breast cancer survival trial

Quote
cafead

cafead

Administrator
Staff member
  • cafead   Sep 23, 2024 at 11:42: AM
via AstraZeneca (AZN.L) said on Monday its experimental precision drug developed with Japan's Daiichi Sankyo (4568.T) did not significantly improve overall survival for patients with a type of breast cancer in a late-stage trial.

article source
 




Top Bottom
Back
Quote